When asked about the relevance of offering an FCR intervention specifically to breast cancer survivors who are carriers of a BRCA1/2 genetic mutation, women strongly affirmed their special needs particularly in relation to their younger age and greater risk of cancer recurrence, raised several unique issues (e.g., decisions about having children and possibility of leaving their children motherless). This evidence concerns the gene BRCA1 and cancer.